Investigación

Tratamiento del cáncer pediátrico

Buscador de publicaciones

Publicaciones

  • Mensali, N, Köksal, H, Joaquina, S, Wernhoff, P, Casey, NP, Romecin, P, Panisello, C, Rodriguez, R, Vimeux, L, Juzeniene, A, Myhre, MR, Fåne, A, Ramírez, CC, Maggadottir, SM, Duru, AD, Georgoudaki, AM, Grad, I, Maturana, AD, Gaudernack, G, Kvalheim, G, Carcaboso AM, de Alava, E, Donnadieu, E, Bruland, OS, Menendez, P, Inderberg, EM and Wälchli, S.

    ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma

    NATURE COMMUNICATIONS . 14(1): . Nº de citas: 11

    [doi:10.1038/s41467-023-39097-x]

  • Aschero MR, Castillo H, Baulenas-Farrés M, Resa-Parés C, Jiménez-Cabaco A, Rodriguez E, Monterrubio C, Pérez-Jaume S, Suñol M, Chantada G, Lavarino C, Mora J and Carcaboso AM.

    Prognostic value of xenograft engraftment in patients with metastatic high-risk neuroblastoma

    PEDIATRIC BLOOD & CANCER . 70(6): . Nº de citas: 3

    [doi:10.1002/pbc.30318]

  • Thirant, C, Peltier, A, Durand, S, Kramdi, A, Louis-Brennetot, C, Pierre-Eugene, C, Gautier, M, Costa, A, Grelier, A, Zaïdi S, Gruel, N, Jimenez, I, Lapouble, E, Pierron, G, Sitbon, D, Brisse, HJ, Gauthier, A, Freneaux, P, Grossetête S, Baudrin, LG, Raynal, V, Baulande, S, Bellini, A, Bhalshankar, J, Carcaboso AM, Geoerger, B, Rohrer, H, Surdez, D, Boeva, V, Schleiermacher, G, Delattre, O and Janoueix-Lerosey, I.

    Reversible transitions between noradrenergic and mesenchymal tumor identities define cell plasticity in neuroblastoma

    NATURE COMMUNICATIONS . 14(1): 2575-2575. Nº de citas: 21

    [doi:10.1038/s41467-023-38239-5]

  • Cristobal Langdon Montero, Hinojosa J, Munuera-del Cerro JL, Gómez-Chiari M, Haag OH, Veneri A, Valldeperes A, Valls-Esteve A, Adell NE, Santamaria V, Cruz-Martínez O and Morales-La Madrid A.

    3D printing as surgical planning and training in pediatric endoscopic skull base surgery-Systematic review and practical example

    INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY . 168: 111543-111543. Nº de citas: 7

    [doi:10.1016/j.ijporl.2023.111543]

  • Erker C, Mynarek M, Bailey S, Mazewski CM, Baroni L, Massimino M, Hukin J, Aguilera D, Cappellano AM, Ramaswamy V, Lassaletta A, Perreault S, Kline CN, Rajagopal R, Michaiel G, Zapotocky M, Santa-María López V, Morales-La Madrid A, Cacciotti C, Sandler ES, Hoffman LM, Klawinski D, Khan S, Salloum R, Hoppmann AL, Larouche V, Dorris K, Toledano H, Gilheeney SW, Abdelbaki MS, Wilson B, Tsang DS, Knipstein J, Oren MY, Shah S, Murray JC, Ginn KF, Wang ZJ, Fleischhack G, Obrecht D, Tonn S, Harrod VL, Matheson K, Crooks B, Strother DR, Cohen KJ, Hansford JR, Mueller S, Margol A, Gajjar A, Dhall G, Finlay JL, Northcott PA, Rutkowski S, Clifford SC, Robinson G, Bouffet E and Lafay-Cousin L.

    Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation-Sparing Approaches: An International Cohort Study

    JOURNAL OF CLINICAL ONCOLOGY . 41(10): 1921-1932. Nº de citas: 8

    [doi:10.1200/JCO.21.02968]

  • Tucker ER, Jiménez I, Chen L, Bellini A, Gorrini C, Calton E, Gao Q, Che H, Poon E, Jamin Y, Martins Da Costa B, Barker K, Shrestha S, Hutchinson JC, Dhariwal S, Goodman A, Del Nery E, Gestraud P, Bhalshankar J, Iddir Y, Saberi-Ansari E, Saint-Charles A, Geoerger B, Marques Da Costa ME, Pierre-Eugene C, Janoueix-Lerosey I, Decaudin D, Némati F, Carcaboso AM, Surdez D, Delattre O, George SL, Chesler L, Tweddle DA and Schleiermacher G.

    Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models

    CLINICAL CANCER RESEARCH . 29(7): 1317-1331. Nº de citas: 11

    [doi:10.1158/1078-0432.CCR-22-2274]

  • van Heerden J, Balagadde-Kambugu J, Angom R, Lusobya RC, Chantada G, Desjardins L, Fabian ID, Israels T, Paintsil V, Hessissen L, Diouf MN, Elayadi M, Turner SD, Kouya F and Geel JA.

    Evaluating the baseline survival outcomes of the "six Global Initiative for Childhood Cancer index cancers" in Africa.

    PEDIATRIC HEMATOLOGY AND ONCOLOGY . 40(3): 203-223. Nº de citas: 4

    [doi:10.1080/08880018.2022.2140860]

  • Pascual-Pastó G, Resa-Parés C, Castillo H, Aschero MR, Baulenas-Farrés M, Vilà-Ubach M, Burgeño-Sandoval V, Balaguer-Lluna L, Cuadrado-Vilanova M, Gene-Olaciregui N, Martinez N, Pérez-Jaume S, de Alava, E, Tirado, OM, Lavarino C, Mora J and Carcaboso AM.

    Low Bcl-2 is a robust biomarker of sensitivity to nab-paclitaxel in Ewing sarcoma

    BIOCHEMICAL PHARMACOLOGY . 208: 115408-115408. Nº de citas: 6

    [doi:10.1016/j.bcp.2022.115408]

  • Lomba, L, Polo, A, Alejandre, J, Martinez N and Giner, B.

    Solubility enhancement of caffeine and furosemide using deep eutectic solvents formed by choline chloride and xylitol, citric acid, sorbitol or glucose

    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY . 79: . Nº de citas: 14

    [doi:10.1016/j.jddst.2022.104010]

  • Bouchoucha, Y, Matet, A, Berger, A, Carcaboso AM, Gerrish, A, Moll, A, Jenkinson, H, Ketteler, P, Dorsmank, JC, Chantada G, Beck-Popovic, M, Munier, F, Aerts, I, Doz, F and Golmard, L.

    Retinoblastoma: From genes to patient care

    EUROPEAN JOURNAL OF MEDICAL GENETICS . 66(1): 104674-104674. Nº de citas: 8

    [doi:10.1016/j.ejmg.2022.104674]